Amanda B. Payne

发表

Seroepidemiologic Survey of Epidemic Cholera in Haiti to Assess Spectrum of Illness and Risk Factors for Severe Disease

Gordana Derado, Brendan R. Jackson, Peter Gerner-Smidt, 2013, The American journal of tropical medicine and hygiene.

Acute chest syndrome is associated with single nucleotide polymorphism‐defined beta globin cluster haplotype in children with sickle cell anaemia

M. DeBaun, J. Keefer, W. Hooper, 2013, British journal of haematology.

Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.

J. Mehal, W. Hooper, L. Richardson, 2020, Annals of emergency medicine.

Exercise capacity and clinical outcomes in adults followed in the Cooperative Study of Sickle Cell Disease (CSSCD)

A. Payne, S. Badawy, M. Rodeghier, 2018, European journal of haematology.

Association between baseline fetal hemoglobin levels and incidence of severe vaso‐occlusive pain episodes in children with sickle cell anemia

D. Arking, J. Keefer, P. Bhatnagar, 2013, Pediatric blood & cancer.

Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

M. DeBaun, S. Ofori-Acquah, W. Hooper, 2012, Blood.

cell disease reduced incidence of acute chest syndrome among children with sickle Heme oxygenase-1 gene promoter polymorphism is associated with

M. DeBaun, S. Ofori-Acquah, W. Hooper, 2013 .

High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.

H. Austin, W. Hooper, C. Miller, 2014, Ethnicity & disease.

Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022

Elizabeth B White, I. Spicknall, A. Gundlapalli, 2022, MMWR. Morbidity and mortality weekly report.

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022

Matthew M. Cole, Elizabeth A Torrone, E. Banerjee, 2022, MMWR. Morbidity and mortality weekly report.

Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2

Manish M Patel, A. Randolph, I. Harwayne-Gidansky, 2021, JAMA network open.

Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States

P. Kouides, V. Byams, C. Miller, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States

T. Buckner, V. Byams, C. Miller, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity

W. Hooper, C. Miller, Amanda B. Payne, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023

S. E. Reese, M. Stockwell, R. Link-Gelles, 2023, MMWR. Morbidity and mortality weekly report.

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United States, January 2022–May 2023

Samuel S. Shepard, D. MacCannell, Nicholas A. Kovacs, 2023, MMWR. Morbidity and mortality weekly report.

Occurrence rates of inherited bleeding disorders other than haemophilia and von Willebrand disease among people receiving care in specialized treatment centres in the United States

M. Lewandowska, A. Shapiro, C. Miller, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

William F. Fadel, S. E. Reese, C. Mcevoy, 2023, MMWR. Morbidity and mortality weekly report.

Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 2020

L. Schieve, G. Peacock, J. Panepinto, 2020, Emerging infectious diseases.

Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design

S. E. Reese, R. Link-Gelles, S. Grannis, 2023, Vaccine.

Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen‐Bethesda assay for factor VIII inhibitors

C. Bean, C. Miller, A. Payne, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

HLA-DRB1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study.

C. Kempton, A. Payne, Amanda B. Payne, 2018, Blood advances.

HLA-DRB 1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia : a case-control study

C. Kempton, A. Payne, Amanda B. Payne, 2022 .

Magnetic resonance angiography‐defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose‐6‐phosphate dehydrogenase mutation in children with sickle cell anaemia

Bruce A. Vendt, R. McKinstry, M. DeBaun, 2012, British journal of haematology.

Vital Signs: Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents — Selected U.S. States, 2019

M. Hulihan, L. Schieve, W. Hooper, 2022, MMWR. Morbidity and mortality weekly report.

A study of prospective surveillance for inhibitors among persons with haemophilia in the United States

C. Kempton, A. Neff, D. Brettler, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.